vs
Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and Seritage Growth Properties (SRG). Click either name above to swap in a different company.
Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $4.2M, roughly 1.6× Seritage Growth Properties). On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs -4.9%).
Seritage Growth Properties is a U.S.-headquartered publicly traded real estate investment trust. It owns, redevelops, and manages a diversified portfolio of retail, residential, and mixed-use commercial properties across key U.S. markets, leasing spaces to retail, dining, and service sector tenants.
PRLD vs SRG — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.5M | $4.2M |
| Net Profit | $-19.7M | — |
| Gross Margin | — | — |
| Operating Margin | -314.1% | — |
| Net Margin | -303.5% | — |
| Revenue YoY | 116.7% | -4.9% |
| Net Profit YoY | 38.9% | 55.2% |
| EPS (diluted) | $-0.26 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.2M | ||
| Q3 25 | $6.5M | $4.8M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $4.6M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $3.0M | $3.3M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $5.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-19.7M | $-12.4M | ||
| Q2 25 | — | $-28.5M | ||
| Q1 25 | — | $-22.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-32.3M | $-22.0M | ||
| Q2 24 | — | $-101.2M | ||
| Q1 24 | — | $-19.0M |
| Q4 25 | — | — | ||
| Q3 25 | -314.1% | -258.0% | ||
| Q2 25 | — | -610.2% | ||
| Q1 25 | — | -486.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1145.9% | -673.2% | ||
| Q2 24 | — | -2366.1% | ||
| Q1 24 | — | -328.7% |
| Q4 25 | — | — | ||
| Q3 25 | -303.5% | -259.6% | ||
| Q2 25 | — | -612.6% | ||
| Q1 25 | — | -482.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1075.7% | -675.9% | ||
| Q2 24 | — | -2401.0% | ||
| Q1 24 | — | -328.9% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.26 | $-0.24 | ||
| Q2 25 | — | $-0.53 | ||
| Q1 25 | — | $-0.42 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.43 | $-0.41 | ||
| Q2 24 | — | $-1.82 | ||
| Q1 24 | — | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.0M | $48.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $331.4M |
| Total Assets | $94.8M | $393.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.1M | ||
| Q3 25 | $55.0M | $51.5M | ||
| Q2 25 | — | $71.8M | ||
| Q1 25 | — | $94.3M | ||
| Q4 24 | — | $85.2M | ||
| Q3 24 | $153.6M | $85.6M | ||
| Q2 24 | — | $86.7M | ||
| Q1 24 | — | $114.9M |
| Q4 25 | — | $331.4M | ||
| Q3 25 | $58.5M | $337.7M | ||
| Q2 25 | — | $351.4M | ||
| Q1 25 | — | $381.1M | ||
| Q4 24 | — | $404.5M | ||
| Q3 24 | $156.4M | $417.5M | ||
| Q2 24 | — | $440.4M | ||
| Q1 24 | — | $542.4M |
| Q4 25 | — | $393.8M | ||
| Q3 25 | $94.8M | $558.6M | ||
| Q2 25 | — | $575.7M | ||
| Q1 25 | — | $649.7M | ||
| Q4 24 | — | $677.8M | ||
| Q3 24 | $197.2M | $735.0M | ||
| Q2 24 | — | $758.3M | ||
| Q1 24 | — | $914.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-19.1M | $-34.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-34.9M | ||
| Q3 25 | $-19.1M | $-12.5M | ||
| Q2 25 | — | $-12.0M | ||
| Q1 25 | — | $-9.2M | ||
| Q4 24 | — | $-53.5M | ||
| Q3 24 | $-27.3M | $-15.5M | ||
| Q2 24 | — | $-7.5M | ||
| Q1 24 | — | $-16.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-27.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -912.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
